ICAD
ICAD Inc
Price:  
3.76 
USD
Volume:  
189,085.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ICAD EV/EBITDA

-126.3%
Upside

As of 2025-07-06, the EV/EBITDA ratio of ICAD Inc (ICAD) is -16.71. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICAD's latest enterprise value is 83.26 mil USD. ICAD's TTM EBITDA according to its financial statements is -4.98 mil USD. Dividing these 2 quantities gives us the above ICAD EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.7x - 12.4x 8.8x
Forward P/E multiples 4.7x - 15.2x 10.2x
Fair Price (0.13) - (1.52) (0.99)
Upside -103.4% - -140.3% -126.3%
3.76 USD
Stock Price
(0.99) USD
Fair Price

ICAD EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-03 -16.71
2025-07-02 -16.60
2025-07-01 -16.49
2025-06-30 -16.99
2025-06-27 -17.10
2025-06-26 -17.27
2025-06-25 -16.66
2025-06-24 -16.55
2025-06-23 -16.11
2025-06-20 -16.33
2025-06-18 -16.99
2025-06-17 -16.77
2025-06-16 -17.10
2025-06-13 -16.27
2025-06-12 -16.71
2025-06-11 -17.21
2025-06-10 -17.76
2025-06-09 -17.60
2025-06-06 -17.49
2025-06-05 -17.27
2025-06-04 -16.77
2025-06-03 -17.49
2025-06-02 -17.38
2025-05-30 -17.16
2025-05-29 -16.11
2025-05-28 -16.16
2025-05-27 -16.88
2025-05-23 -16.55
2025-05-22 -16.60
2025-05-21 -17.05
2025-05-20 -17.82
2025-05-19 -17.93
2025-05-16 -17.98
2025-05-15 -17.60
2025-05-14 -17.54
2025-05-13 -17.65
2025-05-12 -16.44
2025-05-09 -15.83
2025-05-08 -16.27
2025-05-07 -15.83
2025-05-06 -15.23
2025-05-05 -15.17
2025-05-02 -15.28
2025-05-01 -14.84
2025-04-30 -14.84
2025-04-29 -14.84
2025-04-28 -14.34
2025-04-25 -14.07
2025-04-24 -14.18
2025-04-23 -13.52